CFP last date
20 May 2024
Call for Paper
June Edition
IJCA solicits high quality original research papers for the upcoming June edition of the journal. The last date of research paper submission is 20 May 2024

Submit your paper
Know more
The week's pick
Responsive image
Enhancing Privacy Preservation: Multi-Attribute Protection with P-Sensitive K-Anonymity

Twinkle Patel Kiran Amin
Random Articles
Reseach Article

Computational Investigation on Anti Cancer Compounds against Aldose Reductase as Anti Diabetic Agents

by Naresh Babu Muppalaneni, Prof. Allam Appa Rao
journal cover thumbnail

International Journal of Computer Applications
Foundation of Computer Science (FCS), NY, USA
Volume 31 - Number 2
Year of Publication: 2011
Authors: Naresh Babu Muppalaneni, Prof. Allam Appa Rao
10.5120/3795-5226

Naresh Babu Muppalaneni, Prof. Allam Appa Rao . Computational Investigation on Anti Cancer Compounds against Aldose Reductase as Anti Diabetic Agents. International Journal of Computer Applications. 31, 2 ( October 2011), 14-18. DOI=10.5120/3795-5226

@article{ 10.5120/3795-5226,
author = { Naresh Babu Muppalaneni, Prof. Allam Appa Rao },
title = { Computational Investigation on Anti Cancer Compounds against Aldose Reductase as Anti Diabetic Agents },
journal = { International Journal of Computer Applications },
issue_date = { October 2011 },
volume = { 31 },
number = { 2 },
month = { October },
year = { 2011 },
issn = { 0975-8887 },
pages = { 14-18 },
numpages = {9},
url = { https://ijcaonline.org/archives/volume31/number2/3795-5226/ },
doi = { 10.5120/3795-5226 },
publisher = {Foundation of Computer Science (FCS), NY, USA},
address = {New York, USA}
}
%0 Journal Article
%1 2024-02-06T20:17:03.973508+05:30
%A Naresh Babu Muppalaneni
%A Prof. Allam Appa Rao
%T Computational Investigation on Anti Cancer Compounds against Aldose Reductase as Anti Diabetic Agents
%J International Journal of Computer Applications
%@ 0975-8887
%V 31
%N 2
%P 14-18
%D 2011
%I Foundation of Computer Science (FCS), NY, USA
Abstract

An investigation has been carried out to find out the anti cancerous compounds can exhibit anti diabetic against aldose reductase. Diabetes and cancer are common diseases worldwide. In our study we have taken 17 anti cancerous compounds from inhouse chalcones database to perform docking studies. It reveals that there are some compounds which are binding with high affinity than the average docking score -126.048 kcal/mol of ligands of the 1AH3 protein. The anti cancer compounds exhibit high docking score than the average -126.048 kcal/mol. The anti cancer compound can be used as anti diabetic.

References
  1. Edward Giovannucci Et Al, Diabetes Care, Volume 33, Number 7, July 2010
  2. Ohta K, Endo T, Haraguchi K, Hershman JM, Onaya T. Ligands for peroxisome proliferator-activated receptor gamma inhibit growth and induce apoptosis of human papillary thyroid carcinoma cells. J Clin Endocrinol Metab 2001;86:2170–2177
  3. Panigrahy D, Huang S, Kieran MW,Kaipainen A. PPAR gamma as a therapeutic target for tumor angiogenesis and metastasis. Cancer Biol Ther 2005;4: 687–693
  4. Ondrey F. Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention. Clin Cancer Res 2009; 15:2–8
  5. Clay CE, Namen AM, Atsumi G, Trimboli AJ, Fonteh AN, High KP, Chilton FH. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells. J Investig Med 2001; 49:413–420
  6. Clay CE, Monjazeb A, Thorburn J, Chilton FH, High KP. 15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPAR gamma in breast cancer cells. J Lipid Res 2002;43: 1818–1828
  7. Palakurthi SS, Aktas H, Grubissich LM, Mortensen RM, Halperin JA. Anticancer effects of thiazolidinediones are independent of peroxisome proliferator-activated receptor gamma and mediated by inhibition of translation initiation. Cancer Res 2001;61:6213–6218
  8. Kitchen DB, Decornez H, Furr JR, Bajorath J (2004). "Docking and scoring in virtual screening for drug discovery: methods and applications". Nature reviews. Drug discovery 3 (11): 935–49. doi:10.1038/nrd1549. PMID 15520816
  9. Wang R, Y Lu, S Wang 2003 Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem 46:2287-2303.
  10. Clark RD, A Strizhev, JM Leonard, JF Blake, JB Matthew 2002 Consensus scoring for ligand/protein interactions. J Mol Graph Model 20:281-295.
  11. Charifson PS, JJ Corkery, MA Murcko, WP Walters 1999 Consensus scoring: A method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J Med Chem 42:5100-5109.
Index Terms

Computer Science
Information Sciences

Keywords

Bioinformatics Docking studies anti cancer anti diabetic

Powered by PhDFocusTM